CLBAX
Price
$34.19
Change
-$0.81 (-2.31%)
Updated
Dec 18 closing price
CMALX
Price
$26.28
Change
-$0.46 (-1.72%)
Updated
Dec 18 closing price
Ad is loading...

CLBAX vs CMALX

Header iconCLBAX vs CMALX Comparison
Open Charts CLBAX vs CMALXBanner chart's image
American Funds American Balanced 529A
Price$34.19
Change-$0.81 (-2.31%)
VolumeN/A
CapitalizationN/A
Crawford Multi-Asset Income
Price$26.28
Change-$0.46 (-1.72%)
VolumeN/A
CapitalizationN/A
CLBAX vs CMALX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBAX vs. CMALX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Hold and CMALX is a Hold.

FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 241B vs. CMALX (147M). CMALX pays higher dividends than CLBAX: CMALX (4.57) vs CLBAX (2.23). CLBAX was incepted earlier than CMALX: CLBAX (23 years) vs CMALX (7 years). CLBAX is a more actively managed with annual turnover of: 171.00 vs. CMALX (35.00). CLBAX has a lower initial minimum investment than CMALX: CLBAX (250) vs CMALX (10000). CMALX (13.13) and CLBAX (12.51) have marching annual gain over last year. CLBAX return over 5 years is better than : 34.39 vs. CMALX (24.95).
CLBAXCMALXCLBAX / CMALX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years7 years-
Gain YTD11.52312.28094%
Front LoadN/AN/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets241B147M163,946%
Annual Yield % from dividends2.234.5749%
Returns for 1 year12.5113.1395%
Returns for 3 years13.2119.4568%
Returns for 5 years34.3924.95138%
Returns for 10 years58.66N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALEX18.65-0.21
-1.11%
Alexander & Baldwin
CAR89.17-1.62
-1.78%
Avis Budget Group
WAB198.19-4.11
-2.03%
Wabtec
KIRK1.79-0.04
-2.19%
Kirkland's
LRMR4.32-0.51
-10.56%
Larimar Therapeutics